(Q81612489)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18615002%20AND%20SRC:MED&resulttype=core&format=json

10 January 2020

title

The role of ethnicity in variability in response to drugs: focus on clinical pharmacology studies (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18615002%20AND%20SRC:MED&resulttype=core&format=json

10 January 2020

1 reference

S U Yasuda

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18615002%20AND%20SRC:MED&resulttype=core&format=json

10 January 2020

L Zhang

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18615002%20AND%20SRC:MED&resulttype=core&format=json

10 January 2020

S-M Huang

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18615002%20AND%20SRC:MED&resulttype=core&format=json

10 January 2020

publication date

9 July 2008

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18615002%20AND%20SRC:MED&resulttype=core&format=json

Clinical Pharmacology & Therapeutics

10 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18615002%20AND%20SRC:MED&resulttype=core&format=json

10 January 2020

volume

84

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18615002%20AND%20SRC:MED&resulttype=core&format=json

10 January 2020

page(s)

417-423

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18615002%20AND%20SRC:MED&resulttype=core&format=json

10 January 2020

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18615002%20AND%20SRC:MED&resulttype=core&format=json

Drug-metabolizing enzymes: evidence for clinical utility of pharmacogenomic tests

10 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2008.141

7 January 2021

Drug interaction studies: study design, data analysis, and implications for dosing and labeling

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2008.141

7 January 2021

The conduct of in vitro and in vivo drug-drug interaction studies: a Pharmaceutical Research and Manufacturers of America (PhRMA) perspective.

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2008.141

7 January 2021

PhRMA white paper on ADME pharmacogenomics.

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2008.141

7 January 2021

CYP3A5 genetic polymorphisms in different ethnic populations

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2008.141

7 January 2021

The pharmacokinetics and metabolic disposition of tacrolimus: a comparison across ethnic groups

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2008.141

7 January 2021

Tacrolimus dose in black renal transplant recipients

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2008.141

7 January 2021

Rosuvastatin pharmacokinetics and pharmacogenetics in white and Asian subjects residing in the same environment

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2008.141

7 January 2021

Influence of CYP2C9 and VKORC1 1173C/T genotype on the risk of hemorrhagic complications in African-American and European-American patients on warfarin

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2008.141

7 January 2021

Genetic susceptibility to carbamazepine-induced cutaneous adverse drug reactions.

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2008.141

7 January 2021

Medical genetics: a marker for Stevens-Johnson syndrome

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2008.141

7 January 2021

Comprehensive evaluation of variability in nicotine metabolism and CYP2A6 polymorphic alleles in four ethnic populations.

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2008.141

7 January 2021

Ethnic variation in CYP2A6 and association of genetically slow nicotine metabolism and smoking in adult Caucasians.

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2008.141

7 January 2021

Extensive genetic polymorphism in the human CYP2B6 gene with impact on expression and function in human liver

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2008.141

7 January 2021

Bupropion and 4-OH-bupropion pharmacokinetics in relation to genetic polymorphisms in CYP2B6

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2008.141

7 January 2021

Genetic variability of CYP2B6 in populations of African and Asian origin: allele frequencies, novel functional variants, and possible implications for anti-HIV therapy with efavirenz

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2008.141

7 January 2021

Genetic polymorphisms of CYP2C8 in Japanese population.

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2008.141

7 January 2021

Interethnic and intraethnic variability of CYP2C8 and CYP2C9 polymorphisms in healthy individuals

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2008.141

7 January 2021

A review and assessment of potential sources of ethnic differences in drug responsiveness

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2008.141

7 January 2021

Interethnic differences in genetic polymorphisms of CYP2D6 in the U.S. population: clinical implications

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2008.141

7 January 2021

Natural allelic variants of breast cancer resistance protein (BCRP) and their relationship to BCRP expression in human intestine.

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2008.141

7 January 2021

Frequencies of single nucleotide polymorphisms and haplotypes of organic anion transporting polypeptide 1B1 SLCO1B1 gene in a Finnish population

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2008.141

7 January 2021

Effect of drug transporter genotypes on pravastatin disposition in European- and African-American participants

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2008.141

7 January 2021

Pharmacogenomics of human OATP transporters

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2008.141

7 January 2021

Organic anion transporting polypeptide-1B1 haplotypes in Chinese patients

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2008.141

7 January 2021

Genetic variations and frequencies of major haplotypes in SLCO1B1 encoding the transporter OATP1B1 in Japanese subjects: SLCO1B1*17 is more prevalent than *15

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2008.141

7 January 2021

Distribution of the UGT1A1*28 polymorphism in Caucasian and Asian populations in the US: a genomic analysis of 138 healthy individuals.

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2008.141

7 January 2021

Racial variability in haplotype frequencies of UGT1A1 and glucuronidation activity of a novel single nucleotide polymorphism 686C> T (P229L) found in an African-American

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2008.141

7 January 2021

Genetic polymorphism of UDP-glucuronosyltransferase 2B7 (UGT2B7) at amino acid 268: ethnic diversity of alleles and potential clinical significance

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2008.141

7 January 2021

Genetic polymorphism of vitamin K epoxide reductase (VKORC1) 1173C>T in a Chinese and a Caucasian population

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2008.141

7 January 2021

Identifiers

DOI

10.1038/CLPT.2008.141

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18615002%20AND%20SRC:MED&resulttype=core&format=json

10 January 2020

1 reference